VENKYS | GSK CONSUMER | VENKYS/ GSK CONSUMER |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -53.5 | 39.1 | - | View Chart |
P/BV | x | 2.6 | 11.0 | 23.1% | View Chart |
Dividend Yield | % | 0.5 | 1.0 | 51.4% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
VENKYS Mar-19 |
GSK CONSUMER Mar-19 |
VENKYS/ GSK CONSUMER |
5-Yr Chart Click to enlarge
|
||
High | Rs | 4,725 | 7,819 | 60.4% | |
Low | Rs | 1,787 | 5,832 | 30.6% | |
Sales per share (Unadj.) | Rs | 2,159.8 | 1,136.9 | 190.0% | |
Earnings per share (Unadj.) | Rs | 123.6 | 233.7 | 52.9% | |
Cash flow per share (Unadj.) | Rs | 144.4 | 248.1 | 58.2% | |
Dividends per share (Unadj.) | Rs | 8.00 | 105.00 | 7.6% | |
Dividend yield (eoy) | % | 0.2 | 1.5 | 16.0% | |
Book value per share (Unadj.) | Rs | 625.6 | 973.5 | 64.3% | |
Shares outstanding (eoy) | m | 14.09 | 42.06 | 33.5% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 1.5 | 6.0 | 25.1% | |
Avg P/E ratio | x | 26.3 | 29.2 | 90.2% | |
P/CF ratio (eoy) | x | 22.5 | 27.5 | 81.9% | |
Price / Book Value ratio | x | 5.2 | 7.0 | 74.2% | |
Dividend payout | % | 6.5 | 44.9 | 14.4% | |
Avg Mkt Cap | Rs m | 45,874 | 287,083 | 16.0% | |
No. of employees | `000 | 5.5 | 3.8 | 143.4% | |
Total wages/salary | Rs m | 1,945 | 6,446 | 30.2% | |
Avg. sales/employee | Rs Th | 5,520.9 | 12,440.2 | 44.4% | |
Avg. wages/employee | Rs Th | 352.8 | 1,677.0 | 21.0% | |
Avg. net profit/employee | Rs Th | 315.9 | 2,556.7 | 12.4% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 30,431 | 47,820 | 63.6% | |
Other income | Rs m | 290 | 4,326 | 6.7% | |
Total revenues | Rs m | 30,721 | 52,146 | 58.9% | |
Gross profit | Rs m | 3,084 | 11,410 | 27.0% | |
Depreciation | Rs m | 294 | 606 | 48.5% | |
Interest | Rs m | 316 | 8 | 4,044.9% | |
Profit before tax | Rs m | 2,765 | 15,123 | 18.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,024 | 5,295 | 19.3% | |
Profit after tax | Rs m | 1,741 | 9,828 | 17.7% | |
Gross profit margin | % | 10.1 | 23.9 | 42.5% | |
Effective tax rate | % | 37.0 | 35.0 | 105.7% | |
Net profit margin | % | 5.7 | 20.6 | 27.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 8,904 | 52,674 | 16.9% | |
Current liabilities | Rs m | 5,877 | 18,140 | 32.4% | |
Net working cap to sales | % | 9.9 | 72.2 | 13.8% | |
Current ratio | x | 1.5 | 2.9 | 52.2% | |
Inventory Days | Days | 25 | 36 | 70.5% | |
Debtors Days | Days | 37 | 29 | 124.5% | |
Net fixed assets | Rs m | 5,675 | 4,798 | 118.3% | |
Share capital | Rs m | 141 | 421 | 33.5% | |
"Free" reserves | Rs m | 8,674 | 40,527 | 21.4% | |
Net worth | Rs m | 8,815 | 40,947 | 21.5% | |
Long term debt | Rs m | 399 | 0 | - | |
Total assets | Rs m | 15,573 | 60,681 | 25.7% | |
Interest coverage | x | 9.8 | 1,939.8 | 0.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 2.0 | 0.8 | 248.0% | |
Return on assets | % | 13.2 | 16.2 | 81.5% | |
Return on equity | % | 19.8 | 24.0 | 82.3% | |
Return on capital | % | 33.4 | 37.0 | 90.5% | |
Exports to sales | % | 0.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 200 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 200 | 3,171 | 6.3% | |
Fx outflow | Rs m | 725 | 1,770 | 41.0% | |
Net fx | Rs m | -525 | 1,401 | -37.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,589 | 6,711 | 23.7% | |
From Investments | Rs m | -383 | -3,351 | 11.4% | |
From Financial Activity | Rs m | -1,204 | -3,768 | 32.0% | |
Net Cashflow | Rs m | 2 | -408 | -0.5% |
Indian Promoters | % | 56.1 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 72.5 | - | |
Indian inst/Mut Fund | % | 8.8 | 0.8 | 1,100.0% | |
FIIs | % | 3.2 | 12.0 | 26.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 31.9 | 14.8 | 215.5% | |
Shareholders | 20,089 | 26,457 | 75.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare VENKYS With: TATA COFFEE RASOYA PROTEINS VADILAL INDUSTRIES MCLEOD RUSSEL TILAKNAGAR IND.
Compare VENKYS With: TIGER BRANDS (S. Africa) COCA COLA (US) NESTLE (Switz.) AVI LTD. (S. Africa)
The SGX Nifty opened on a negative note today. At 8:00 am, it was trading down by 38 points, or 0.27% lower at 14,420 levels.
HDFC BANK share price has hit a 52-week high. It is presently trading at Rs 1,498. BSE 500 Index is down by 0.2% at 18,994. Within the BSE 500, HDFC BANK (up 1.7%) and GSK CONSUMER (up 5.1%) are among the top gainers, while top losers are CORPORATION BANK and HATHWAY CABLE.
For the quarter ended June 2020, VENKYS (I) LIMITED has posted a net profit of Rs 470 m (down 24.0% YoY). Sales on the other hand came in at Rs 5 bn (down 40.2% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.
Does the company with one of the fastest-growing QSR chains in India have sound prospects?
For the quarter ended December 2019, VENKYS (I) LIMITED has posted a net profit of Rs 59 m (down 108.7% YoY). Sales on the other hand came in at Rs 9 bn (up 8.4% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.
For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.
More Views on NewsMy new guide will show you the huge potential in future proof businesses.
The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
More